je.st
news
MRA Applauds Latest Melanoma Drug Approval
2014-12-29 01:14:14| drugdiscoveryonline Home Page
The Melanoma Research Alliance (MRA) recently welcomed news that the U.S. Food & Drug Administration (FDA) has granted approval to Bristol Myers-Squibb’s new immunotherapy drug, Opdivo (nivolumab), for the treatment of metastatic melanoma
Tags: latest
drug
approval
melanoma
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||